ÂÜÀòÂÒÂ×

Liz Shanahan was appointed as Non-Executive Director of AMS in August 2022. She is currently a Non-Executive Director of Inspiration Healthcare Group plc and Celadon Pharmaceuticals plc (previously Summerway Capital plc), both of which are AIM-listed.

She is a life sciences entrepreneur with extensive experience advising leading global pharmaceutical and healthcare organizations on their communications. Most recently, she was a Non-Executive Director of UDG Healthcare plc, a company that was listed on the London Stock Exchange and a constituent of the FTSE 250 up until its £2.8 billion takeover in August 2021. Until 2014, she was Global Head of Healthcare & Lifesciences at the NYSE-listed management consultancy, FTI Consulting Inc., which in 2007 acquired the communications business Santé Communications, founded by Liz in 1995. Liz is a Trustee of CW, the charitable arm of Chelsea & Westminster Foundation Trust Hospital in London, and a member of the organization’s Innovations Advisory Board.

Alongside her Board appointments, she is a business advisor and Executive coach.